Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Atossa Therapeutics (ATOS)

NASDAQ:ATOS

ATOS

Atossa Therapeutics

RESEARCH TOOLSreports

Atossa Therapeutics (ATOS) Stock News & Sentiment

Compare

2,480 Followers

Atossa Therapeutics: Buy Rating on Promising DMD Advancements and Strategic Growth Potential

Premium

Ratings

Atossa Therapeutics: Buy Rating on Promising DMD Advancements and Strategic Growth Potential

12d ago

ATOS

Premium

Ratings

Promising Clinical Trial Results of Z-endoxifen Support Buy Rating for Atossa Therapeutics

13d ago

ATOS

Premium

Ratings

Strategic Advancements and Regulatory Progress Boost Atossa Therapeutics’ Outlook

24d ago

ATOS

Premium

Company Announcements

Atossa Completes FDA Meeting on Regulatory Strategies

24d ago

ATOS

Premium

Ratings

Atossa Therapeutics: Strategic Advancements in Breast Cancer Treatment Drive Buy Rating

2M ago

ATOS

Premium

Company Announcements

Atossa Therapeutics Reports Increased Q3 Losses Amid R&D Focus

2M ago

ATOS

Premium

Ratings

Atossa Therapeutics: Advancements in Z-endoxifen Development and Strategic Leadership Enhancements Drive Buy Rating

2M ago

ATOS

More ATOS News >

ATOS News on the Web

2025-12-15

Why Atossa Therapeutics, Inc.’s (ATOS) Stock Is Down 11.03%

AAII

Neutral

2025-12-11

Atossa Therapeutics Secures FDA Rare Pediatric Disease Designation for (Z)-Endoxifen, Opening Door to Priority Review Voucher Opportunity

Market Chameleon

Neutral

2025-12-11

Why Atossa Therapeutics, Inc.’s (ATOS) Stock Is Up 9.41%

AAII

Neutral

2025-12-10

Why Atossa Therapeutics, Inc.’s (ATOS) Stock Is Up 6.15%

AAII

Neutral

2025-12-02

Why Atossa Therapeutics, Inc.’s (ATOS) Stock Is Down 5.42%

AAII

Neutral

2025-10-22

New Strong Sell Stocks for Oct. 22

Zacks

Neutral

2025-10-17

Why Atossa Therapeutics, Inc.’s (ATOS) Stock Is Down 6.01%

AAII

Neutral

2025-10-14

New Strong Sell Stocks for Oct. 14th

Zacks

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ATOS’s Media Buzz Sentiment?

Currently, no data Available

What is ATOS’s weekly average amount of articles?

Currently, no data Available

What is ATOS’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DVAXDynavax

AGIOAgios Pharma

ADUSAddus Homecare

ENSGThe Ensign Group

NVONovo Nordisk

Showing the stocks with the most bullish news sentiment over the past week